My WebLink
|
Help
|
About
|
Sign Out
Home
COM 0140.006 2002-2004
ClerkCouncil
>
Council Records
>
Communications
>
2002-2004
>
COM 0140.006 2002-2004
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/12/2008 9:32:38 PM
Creation date
5/10/2008 12:15:36 AM
Metadata
Fields
Template:
Communications
Communications - Type
COM
Communications - Council Term
2002-2004
Communication
0140
Point
006
Author
Submitted by Dennis Shields, Reverend, The Religion of Jesus Church
Communications - Referred To
COUNCIL
Comments
Presented: Council - 3/19/03
Document Relationships
BIL 059 Draft 01 2002-2004
(Related)
Path:
\Council Records\Bills\2002-2004
COM 0140.000 2002-2004
(Related)
Path:
\Council Records\Communications\2002-2004
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
19
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Fhe effects of Ibogaine treatment are e iewed in three cuteeones: acute, intermediate and long-term. <br /> the acute and intermediate effects have s'ometintes been referred to as the et7erts and aftereffects. <br /> I-he two major effects of Ibogaine are A I the ability to interrupt narcotic and stimulant withdrawal <br /> and Bf the attenuation or eLimina[ion of the craving to continue to seal. and usr opiates. stimulants <br /> ,utd alcohol I Lotsof 198. 1986. 19891. Knowledge concerning the use of Ibogaine in treating alcohol <br /> dependence is limited tu: I I a single alcohol-onh~ dependent patient and_ I [he attenuation and, in <br /> some cases. cessation of alcohol we in persons treated for poh-drug dependence disorders. Ibogaine'. <br /> ability [o treat nicotine dependence Q.otsot: 1991 I has been seen in pok-drug dependent subjecn <br /> [reefed primarih for opiate and/or cocaine use . <br /> First, [here are some general considerations. The priman obligations of the treatment team are <br /> tintr-fold: I l to cam the trust of the patient. to main[ain the cumfon otthr patient-? ~ to assist the <br /> patients in interrupting then chemical dependence and ~i to supph [he pse chosocml support networ6 <br /> needed be the majority of patients to enable them to develop a sense of personal accomplishment and <br /> the abilih to function us produc[ive members of socien. Ihis is a process the Dutch treatment <br /> comrtmnin refers [o us normalitation_ <br /> In the Lotsof Proceduresm. for which a martual is now beme prepared. [he sense nt conflict ;een in <br /> mos[ treatment modalities hetween the doctor and patiem over the itmnedia[e eeasme of drug use <br /> does not exist. fhe patients haer been allowed, if narcotic-dependrn[. [o continue [hen use of <br /> narcotics until a cenam time prwr to [reatment with Ibogaine- I here is no cunfLci oe er opiate uiC <br /> before treaunent us our position ties been that Ibogaine will either wort. to interrupt chemical <br /> dependence ur it will not Patients dependent on stimulanti ore not maintained on ;timulants and <br /> this has not created a problem for [he patients or the medical staff. <br /> Prior [u our conducting Ibogaine treatments m hospitals, addicted patients were allowed to usr their <br /> personal supply oC narcotics until [he ce ening before treatment. However, during <br /> hospital-udtninistered Ibogaine sessions. the narcotic-dependent patient is maintained tin medications <br /> prescribed he the principal tin estigator during the three [o the day inta6r process preceding their <br /> ueamtrnt with Ibogaine. Le en under these circuntstancen. patient disnatst o[ the medical <br /> establishmen[ and their e~[reme tear of going into withdrawal has resulted in the smuggling of <br /> narcotics into hospiml environments. In order to protect the patien[ fium possible overdose due to <br /> narcotics. stimulants ur other <Lvgs. a thorough phe sisal c~ammation a perfornted tin all patients <br /> upon their utLnission to hosptml environments- Che c~anunu[ion wtd a scorch ul the patienf~ <br /> possessnaa prior to treatment with Ibogaine xne two iropurtunt functions. fhe ties[. is to limn the <br /> possibilin of accidental oeerdose from ,ecrtted drugs- I he ,ccond. is [e. prue Cdr a complete <br /> underswndmg of the puoent ~ physical health, since main of the people seeAmg treannen[ for <br /> chemical dependence haee ntasl.ed carious ;md often numerous medical problems for eeurn or teen <br /> decades he :elf-medieatim~ with illici[ drugs <br /> ~aCL fF EFFE;C~fti <br /> RECiIMkih <br /> 1-he acute ettec[s of lbogainr ;ire dramatic. fhe initial reaction a usualh no[ed wuhin tom-tiee <br /> minu[es after the oral dose rind lull effrcts are _eneratle ce idem within [wu to mu and a half hours. <br /> fhe eudiest subjec[iee indicunon be patients of lbogaines effects is the report of a pore asne <br /> oscillaring sound. Che pa[ien[ [ends io lie down and, ifasAed to stand or wal6- shows stns of uta~ia_ <br /> Che protocol for the Lotsof Proceduresm stipulates [hat the patiem remain in bed wuh as little <br /> <br /> movement us possible Itom [he time of Ibogaine administration, as nausea associated with Ibogaine <br /> <br /> use has pnn en [o he motion-related or. in later stages I those longer than four hour, after <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.